Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 ...

A newly released independent research review is contributing fresh scientific perspective to the ongoing discussion around ...

City of Hope has launched a national clinical trial network designed to improve cancer care and reach medically-underserved ...

The FDA-approved trial in Arizona explores whole-mushroom psilocybin therapy for PTSD with first responders and veterans.

December 26, 2025 A newly released clinical review is drawing attention within medical and regulatory communities by consolidating available evidence on the side-effect profile of a widely prescribed ...

A federally funded clinical trial suggests knowing HIV viral load (number of HIV particles in the body) doesn’t improve the ...

UH and Case Western researchers found income and property ownership, not race, determine who accesses potentially life-saving ...

Comparative trials are among the hardest studies to execute in medtech, especially when the control arm is a long-established ...

Palisade extended its winning streak to a fourth straight day on Wednesday, jumping 5.26 percent to close at $2.20 apiece as ...

The US Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target action date for ...

Age-related macular degeneration, the leading cause of vision loss and blindness for Americans 65 and older, is a progressive ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...